HCPCS M0237 at Island Hospital
Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose
What Island Hospital publishes for this code: as an outpatient
| Who pays | Hospital’s fee (lowest – highest) | Doctor’s fee the hospital lists |
|---|---|---|
| Commercial insurance | $842 – $947 | — |
| Medicare Advantage | $526 – $558 | — |
| Medicaid managed care | $214 – $232 | — |
| Other government program | $526 – $554 | — |
| Unknown | $242 – $553 | — |
| Cash price | — | — |
| List price | — | — |
Bills to expect
The hospital’s fee is the price above. Doctors usually send their own bills. Their amounts here are what original Medicare allows in the rest of Washington for 2026, and a private-plan estimate of 118% to 179% of that (the range found across studies of what insurers pay doctors). Those are estimates, not quotes.
| Bill | What it’s for | Original Medicare allows | Private plan estimate |
|---|---|---|---|
| Hospital's fee | The service | — | The price above |
Compare HCPCS M0237 at every Washington hospital, with Medicare’s reference amounts.